Skip to main content
. 2022 Nov 3;20:506. doi: 10.1186/s12967-022-03660-9

Fig. 2.

Fig. 2

Relative FVC increase in Treamid and placebo groups of mITT population, patients in Treamid group with 5–10% relative increase in FVC along with clinically significant relative increase in DLCO (≥15%) are marked with arrows